1. Medtech Insight
  2. >>Device Area
  3. >>Orthopedics

JPM 2021: Conformis Announces ACS Knee For 2H 2021, Integra Weathers Pandemic

 
• By Marion Webb and Reed Miller

The annual J.P. Morgan Healthcare Conference includes presentations from many major medtech companies outlining their growth strategies and expectations for 2021. Here are some of the highlights from the final day of the meeting.

Markus Augusti, president and CEO of orthopedics implant company Conformis, told investors during the J.P. Morgan Healthcare conference that the company is executing on its strategic pivot, announced in August, to develop and market “less-personalized” hip and knee products for treating patients in ambulatory care centers.

The trend toward moving knee and hip surgeries into the outpatient setting has been going on for some time. The Centers for Disease Control and Prevention added 11 procedures...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Orthopedics

More from Device Area

Medtronic To Spin Out Diabetes Unit As New Products Solidify Turn-Around Story

 
• By Shubham Singh

Medtronic’s diabetes spin-out – a process likely to run up to 18 months and involve 20% IPO followed by a split-off for Medtronic shareholders – will allow firm to focus on higher-margin devices.

Pathogen Sharing System Part Of Global Pandemic Agreement

 
• By Neena Brizmohun

Now that the landmark Pandemic Agreement has finally been adopted, work will start on drafting a pathogen access and benefit sharing system that will be voluntary for use by drug companies.

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.